Program Schedule - Day One

Tuesday, October 25, 2016

7:30 - 8:15 am: Breakfast/Registration
Location: Annenberg West Lobby

8:15 - 8:30 am: Welcome Remarks
Kenneth L. Davis, President and CEO, Mount Sinai Health System
Dennis S. Charney, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai; President for Academic Affairs, Mount Sinai Health System

8:35 - 9:05 am: Keynote Address Therapeutic Frontiers in Mental Health
Introduction: Eric J. Nestler, Dean for Academic and Scientific Affairs, Icahn School of Medicine at Mount Sinai
Speaker: Karl Deisseroth, D.H. Chen Professor of Bioengineering and of Psychiatry and Behavioral Sciences, Stanford University; Investigator, Howard Hughs Medical Institute

9:10 - 10:05 am: Panel Discussion – Drug Development in Academic Medical Centers
Moderator:
 Paul J. Kenny, Director, Experimental Therapeutics Institute, Icahn School of Medicine at Mount Sinai
Panelists:

  • Aled Edwards, CEO, Structural Genomics Consortium
  • Kevin Grimes, Co-Director, SPARK Translational Research Program; Associate Professor, Department of Chemical and Systems Biology, Stanford University School of Medicine
  • Craig W. Lindsley, Professor and Co-Director, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University
  • Satwant K. Narula, Vice President, Immunosciences and Fibrotic Diseases, Bristol-Myers Squibb
  • Rupert Vessey, Exec VP and President, Global Research and Early Development, Celgene

10:10 - 10:40 am: Break
Location:
 Annenberg West Lobby

10:45 - 11:15 am: Keynote Address – From Genomics to Therapeutics: Uncovering and Manipulating the Circuitry of Non-Coding Disease Variants and Cancer
Introduction: Marta Filizola, Dean, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai
Speaker: Manolis Kellis, Professor, MIT Computer Science and Artificial Intelligence Lab; Institute Member, Broad Institute of Massachusetts Institute of Technology and Harvard

11:20 am - 12:15 pm: Panel Discussion – Target Identification, Validation and First in Man Approaches 
Moderator: Lakshmi A. Devi, Dean for Academic Development and Enrichment, Icahn School of Medicine at Mount Sinai
Panelists:

  • Kenneth Kaushansky, Senior Vice President for Health Sciences; Dean, School of Medicine, Stony Brook University
  • Avi Ma'ayan, Professor, Department of Pharmacological Sciences; Director, Mount Sinai Center for Bioinformatics, Icahn School of Medicine at Mount Sinai
  • Harlan Robins, Program Head, Full Member, Computational Biology, Fred Hutchinson Cancer Research Center
  • Kári Stefánsson, President, Chief Executive Officer, and Director, deCODE Genetics
  • Jared L. Sterneckert, Group Leader, Induced Pluripotent Stem Cells and Neurodegenerative Disease, DFG-Center for Regenerative Therapies, Technische Universität Dresden

12:20 - 12:50 pm: Keynote Address – Beyond CRISPR
Introduction: 
Scott L. Friedman, Dean for Therapeutic Discovery, Icahn School of Medicine at Mount Sinai
Speaker: 
George Church, Professor, Department of Genetics, Harvard Medical School and Massachusetts Institute of Technology

12:50 - 1:15 pm: Pick-Up Lunch
Location:
 Davis Conference Center, Hess Building

1:15 - 7:30 pm: Trainee Forum and Networking Reception
Location:
 Davis Conference Center, Hess Building